van der Linden Edwin, Kroft Lucia J M, Dijkstra P D Sander
Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
J Vasc Interv Radiol. 2007 Jun;18(6):741-7. doi: 10.1016/j.jvir.2007.02.018.
To evaluate the safety and clinical benefit of vertebral tumor treatment by combined radiofrequency ablation (RFA) and vertebroplasty, for pain reduction in patients who are unable to benefit from noninvasive treatment methods.
Twelve patients with painful vertebral tumors with posterior wall defect, in whom medical treatment together with radiation therapy and/or chemotherapy had failed, were treated with RFA combined with vertebroplasty. Procedures were performed using multislice CT-fluoroscopy and lateral C-arm fluoroscopic guidance. All patients had posterior wall defects of the vertebra being treated. Ten had lytic posterior wall destruction and two had posterior wall fracture. The visual analog scale (VAS) pain score was measured before, one week after, and three months after treatment. VAS patient satisfaction score was measured before and one week after treatment. The VAS score range was 0-20. The analgesic use was evaluated before and four weeks after treatment and complications were monitored.
Combined RFA and vertebroplasty treatment was technically successful in all patients. Pain significantly decreased after treatment: the mean VAS pain score before treatment was 17.33 +/- 2.46 (range, 13-20) versus 9.25 +/- 4.81 (range, 2-18) one week after treatment (P < .001) and was 7.00 +/- 5.26 (range, 1-14) three months after treatment (P = .020). The mean VAS satisfaction score of all patients was 15.83 +/- 4.26 (range, 4-20). Analgesic use decreased after treatment. No serious treatment related complications occurred.
RFA in combination with vertebroplasty for treating vertebral tumors with posterior wall defect appeared safe, and reduced pain substantially in patients who did not benefit from other noninvasive treatment methods.
评估联合射频消融(RFA)和椎体成形术治疗椎体肿瘤的安全性和临床益处,以减轻无法从非侵入性治疗方法中获益的患者的疼痛。
12例后壁缺损的疼痛性椎体肿瘤患者,其药物治疗联合放射治疗和/或化疗均失败,接受了RFA联合椎体成形术治疗。手术在多层CT透视和侧位C形臂透视引导下进行。所有患者均有正在治疗椎体的后壁缺损。10例为溶骨性后壁破坏,2例为后壁骨折。在治疗前、治疗后1周和3个月测量视觉模拟量表(VAS)疼痛评分。在治疗前和治疗后1周测量VAS患者满意度评分。VAS评分范围为0 - 20。在治疗前和治疗后4周评估镇痛药物使用情况,并监测并发症。
联合RFA和椎体成形术治疗在所有患者中技术上均获成功。治疗后疼痛显著减轻:治疗前VAS疼痛评分平均为17.33±2.46(范围13 - 20),治疗后1周为9.25±4.81(范围2 - 18)(P <.001),治疗后3个月为7.00±5.26(范围1 - 14)(P =.020)。所有患者的VAS满意度评分平均为15.83±4.26(范围4 - 20)。治疗后镇痛药物使用减少。未发生严重的治疗相关并发症。
RFA联合椎体成形术治疗后壁缺损的椎体肿瘤似乎是安全的,并且能使未从其他非侵入性治疗方法中获益的患者的疼痛大幅减轻。